Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study
Published inHIV medicine, vol. 10, no. 1, p. 12-18
Publication date2009
Abstract
Keywords
- AIDS-Related Opportunistic Infections/*complications/drug therapy
- Adult
- Anti-HIV Agents/*therapeutic use
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- Epidemiologic Methods
- Female
- *Hiv-1
- Hepatitis B/*complications/drug therapy
- Hepatitis B e Antigens/drug effects
- Humans
- Lamivudine/*therapeutic use
- Liver Diseases/drug therapy/*etiology
- Male
- Middle Aged
- Recurrence
- Switzerland
- Viral Load
Affiliation
Research group
Citation (ISO format)
BELLINI, C. et al. Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study. In: HIV medicine, 2009, vol. 10, n° 1, p. 12–18. doi: 10.1111/j.1468-1293.2008.00646.x
Main files (1)
Article
Identifiers
- PID : unige:19667
- DOI : 10.1111/j.1468-1293.2008.00646.x
- PMID : 18795964
ISSN of the journal1464-2662